Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1831-1840 of 2933 for cancer

Edit search filters
  1. Study Assessing Safety And Efficacy Of Combination Of BL-8040 And Pembrolizumab In Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202)

    Scottsdale/Phoenix, AZ

  2. A Study To Evaluate Trifluridine/Tipiracil Combined With Bevacizumab Vs Trifluridine/Tipiracil To Treat Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Health And Wellness Coaching To Improve Adherence To Healthy Habits And Treatment Plans In Papillary And Follicular Thyroid Cancer Survivors

    Jacksonville, FL

  4. A Study To Evaluate Regorafenib With Cetuximab Or Panitumumab To Treat Unresectable, Locally Advanced, Or Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. A Study Of Rociletinib (CO-1686) For Patients With A Mutant Form Of Non-Small Cell Lung Cancer.

    Scottsdale/Phoenix, AZ

  6. Radiation Therapy With Durvalumab Or Cetuximab To Treat Patients With Locoregionally Advanced Head And Neck Cancer Who Cannot Take Cisplatin

    Rochester, MN

  7. FES PET/CT In Predicting Response In Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy

    Rochester, MN

  8. Intensity-Modulated Radiation Therapy And Paclitaxel With Or Without Pazopanib Hydrochloride In Treating Patients With Anaplastic Thyroid Cancer

    Jacksonville, FL, Rochester, MN

  9. Gemcitabine Hydrochloride Alone Or With M6620 In Treating Patients With Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Rochester, MN

  10. Phase 1b Safety Study Of CMB305 In Patients With Locally Advanced, Relapsed, Or Metastatic Cancer Expressing NY-ESO-1

    Rochester, MN

.

Mayo Clinic Footer